Results 21 to 30 of about 6,827 (229)

Primary versus salvage intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss

open access: yesLaryngoscope Investigative Otolaryngology, 2023
Objective The objective of this research is to compare primary and salvage intratympanic (IT) steroid treatments in terms of hearing outcomes in patients with idiopathic sudden sensorineural hearing loss (ISSNHL).
Wei‐Che Lan   +8 more
doaj   +1 more source

Efficacy of Intratympanic Dexamethasone Injection in Subjective Idiopathic Tinnitus- An Interventional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Tinnitus is a common and annoying symptom characterised by the perception of sound without any corresponding external stimulus. Subjective idiopathic tinnitus is a subjective form of tinnitus where the perceived sound originates from the ...
KR Radhakrishnan   +3 more
doaj   +1 more source

International consensus (ICON) on treatment of Ménière's disease [PDF]

open access: yes, 2018
Objective: To present the international consensus for recommendations for Ménière's disease (MD) treatment. Methods: Based on a literature review and report of 4 experts from 4 continents, the recommendations have been presented during the 21st IFOS ...
Barbara M   +5 more
core   +1 more source

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear

open access: yesFrontiers in Neuroscience, 2022
BackgroundIntratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL).
Stefan K. Plontke   +5 more
doaj   +1 more source

Nanoparticle drug delivery systems for inner ear therapy: An overview [PDF]

open access: yes, 2017
open7noembargoed_20180701Valente, Filippo; Astolfi, Laura; Simoni, Edi; Danti, Serena; Franceschini, Valeria; Chicca, Milvia; Martini, AlessandroValente, Filippo; Astolfi, Laura; Simoni, Edi; Danti, Serena; Franceschini, Valeria; Chicca, Milvia; Martini,
Astolfi, Laura   +6 more
core   +2 more sources

Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment [PDF]

open access: yes, 2017
Intralabyrinthine schwannoma (ILS) is a rare benign tumor that affects the ends of cochlear and vestibular nerves. In a majority of the cases, it occurs with unilateral progressive sensorineural hearing loss.
Barbara, Maurizio   +6 more
core   +1 more source

Intratympanic dexamethasone in Meniere’s disease

open access: yesEgyptian Journal of Ear, Nose, Throat and Allied Sciences, 2016
AbstractIntroduction: In Meniere’s disease, medical treatment consists of salt restriction, vasodilators, diuretics, and symptomatic therapy for the nausea and diaphoresis associated with spells of vertigo. If medical treatment fails, other modalities of treatment should be considered.
Basil M. N. Saeed   +2 more
openaire   +2 more sources

Delivering Therapeutics to the Cochlea: The Importance of the Patient’s Perspective

open access: yesFrontiers in Cellular Neuroscience, 2019
Hearing loss represents a major sensory impairment in humans with a strong impact on quality of life. The current standard of care for chronic sensorineural hearing loss is limited to hearing aids and implantable devices like cochlear implants ...
Marie-Josée Duran, Ralph Holme
doaj   +1 more source

Prediction of hearing recovery in sudden deafness treated with intratympanic steroids [PDF]

open access: yes, 2018
The present study aims to obtain a probability model allowing the prediction of the auditory recovery in patients affected by sudden sensorineural hearing loss treated exclusively with intratympanic steroids.
Attanasio, G.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy